Topics
Pediatric CNS tumors | Treatment | Immunotherapy | CAR-T-cells
Home > Publications > Topics > Pediatric CNS tumors > Treatment > Immunotherapy > CAR-T-cells
Lin
FY, Stuckert A, Tat C, White M, Ruggieri L, Zhang H, Mehta B,
Lapteva N, Mei Z, Major A, Thakkar S, Shum T, Parikh K, Wu MF,
Lindsay HB, Scherer L, Shekar M, Baxter P, Wang T, Grilley B,
Moeller K, Hicks J, Roy A, Anastas J, Malbari F, Aldave G,
Chintagumpala M, Blaney S, Parsons DW, Brenner MK, Heslop HE,
Rooney CM, Omer B.
Phase
I Trial of GD2.CART Cells Augmented With Constitutive
Interleukin-7 Receptor for Treatment of High-Grade Pediatric CNS
Tumors.
J
Clin Oncol.
2024 May 21:JCO2302019. doi:
10.1200/JCO.23.02019. PMID:
38771986. Interventional study. ˍ
Ronsley R, Bertrand KC, Song EZ, Timpanaro A, Choe M, Tlais D,
Vitanza NA, Park JR.
CAR T cell
therapy for pediatric central nervous system tumors: a
review of the literature and current
North American trials.
Cancer
Metastasis Rev.
2024 Sep 9. doi:
10.1007/s10555-024-10208-4. PMID:
39251462. Review. ˍ